Form 4: United Therapeutics Director Nilda Mesa Sells 325 Shares
SEC Filing
Nilda Mesa, a director at United Therapeutics Corp, sold 325 shares of common stock on March 27, 2024, at a price of $237.8 per share.
Summary
- On March 27, 2024, Nilda Mesa, a director of United Therapeutics Corporation, sold 325 shares of the company's common stock.
- The sale was executed at a price of $237.8 per share.
- Following the transaction, Nilda Mesa directly owns 5,373 shares of United Therapeutics Corp.
- The transaction was reported on a Form 4 filing with the Securities and Exchange Commission.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting a stock sale by a company director. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This sale represents a small percentage of the director's holdings.
Stakeholder Impact
- The sale of shares by a director could be perceived neutrally or slightly negatively by shareholders, depending on the context and reasons for the sale.
Key Dates
| Date | Description |
|---|---|
| 03/27/2024 | Date of stock sale transaction |
| 03/29/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.